AstraZeneca COVID-19 antibody drug offers 83% protection over six months

14 Sept 00:35 Key points summarised by AI

AstraZeneca's antibody drug, AZD74442 (Evusheld), provided 83% protection against COVID-19 over six months for individuals who do not respond well to vaccines.
The therapy also demonstrated therapeutic potential, cutting the risk of symptoms worsening by 88% in mild-to-moderate COVID-19 patients when given within three days of symptom onset.

Suspected drug couriers killed in Phetchaburi; half a tonne of Ice seized

Yesterday 16:06 Key points summarised by AI

Two suspected drug couriers were killed in a shootout with narcotics officers in Phetchaburi province.
Authorities seized approximately half a tonne of crystal methamphetamine, also known as Ice, during the operation.
The incident occurred on Tuesday night after officers tracked a network suspected of transporting large quantities of drugs to southern Thailand.
The suspects, identified as Chattharin and Rungarun, both 27, opened fire when confronted by officers, who returned fire, resulting in their deaths.